prikaz prve stranice dokumenta Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
  Preuzmi
PDF 503.85 KB
Znanstveni rad - Izvorni znanstveni rad
Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
Biomedicines, 10 (2022), 12; 3291. https://doi.org/10.3390/biomedicines10123291
Radić, Mislav; Novak, Srđan; Barešić, Marko; Hećimović, Ana; Perković, Dijana; Tekavec-Trkanjec, Jasna; Mayer, Miroslav; Prus, Višnja; Morović-Vergles, Jadranka; Marasović Krstulović, Daniela; Cerovec, Mislav; Bulat Kardum, Ljiljana; Samaržija, Miroslav; Anić, Branimir

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Radić, M., Novak, S., Barešić, M., Hećimović, A., Perković, D., Tekavec Trkanjec, J. ... Anić, B. (2022). Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). Biomedicines, 10. (12), 3291. doi: 10.3390/biomedicines10123291

Radić, Mislav, et al. "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)." Biomedicines, vol. 10, br. 12, 2022, str. 3291. https://doi.org/10.3390/biomedicines10123291

Radić, Mislav, Srđan Novak, Marko Barešić, Ana Hećimović, Dijana Perković, Jasna Tekavec Trkanjec, Miroslav Mayer, et al. "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)." Biomedicines 10, br. 12 (2022): 3291. https://doi.org/10.3390/biomedicines10123291

Radić, M., et al. (2022) 'Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)', Biomedicines, 10(12), str. 3291. doi: 10.3390/biomedicines10123291

Radić M, Novak S, Barešić M, Hećimović A, Perković D, Tekavec Trkanjec J, i sur.. Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). Biomedicines [Internet]. 19.12.2022. [pristupljeno 28.12.2024.];10(12):3291. doi: 10.3390/biomedicines10123291

M. Radić, et al., "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)", Biomedicines, vol. 10, br. 12, str. 3291, Prosinac 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:108337. [Citirano: 28.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:108337
Podaci o radu
Naslov (engleski)Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
AutorMislav Radić
AutorSrđan Novak
AutorMarko Barešić
AutorAna Hećimović
AutorDijana Perković
AutorJasna Tekavec-Trkanjec
AutorMiroslav Mayer
AutorVišnja Prus
AutorJadranka Morović-Vergles
AutorDaniela Marasović Krstulović
AutorMislav Cerovec
AutorLjiljana Bulat Kardum
AutorMiroslav Samaržija
AutorBranimir Anić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
The aim of this study was to develop a Croatian Delphi-based expert consensus for screening interstitial lung disease (ILD) associated with connective tissue disease (CTD). A systematic literature review was conducted on risk factors for the development of ILD, prevalence and incidence of ILD, diagnostic and screening methods for ILD, and prognosis of ILD in idiopathic inflammatory myopathy (IIM), mixed connective tissue disease (MCTD), primary Sjögren’s syndrome (pSS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc) were performed. Based on the evidence found, experts developed questionnaires for screening and monitoring ILD in each CTD, which were provided via an online survey. Following the electronic survey, two screening algorithms were developed based on the consensus opinions. The detection strategy for ILD included high-resolution computed tomography (HRCT) in addition to pulmonary function testing for IIM, MCTD, and SSc. and pulmonary function testing for newly diagnosed pSS, RA and SLE. However, in patients with identified risk factors for ILD HRCT, these tests should also be performed. A screening strategy for early identification of patients with various CTD-ILD was first developed by a multidisciplinary team of rheumatologists, pulmonologists, and radiologists to identify early CTD patients at risk of ILD, a severe extra-articular manifestation of CTD.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBiomedicines
Brojčani podacivol. 10, br. 12, str. 3291, 3291
e-ISSN2227-9059
DOIhttps://doi.org/10.3390/biomedicines10123291
URN:NBNurn:nbn:hr:184:108337
Datum objave publikacije2022-12-19
URL dokumentahttps://www.mdpi.com/2227-9059/10/12/3291
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2023-01-31 09:59:58